Data / Form D filings / Celularity Inc.
Celularity Inc.: Form D filings
Celularity Inc., a biotechnology company in Warren, NJ, filed 2 Form D notices with the SEC between 2017 and 2018. The latest, on November 13, 2018, reports $77.7 million sold of a $202.7 million offering to 5 investors.
Find out what Celularity Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 33 Technology DRIVE, Warren, NJ, 07059
- Phone
- (908) 673-9000
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2016
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1716918
The full lists. Form D filings in New Jersey: 714 rows, $35.70, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 13, 2018 | New notice | $202,699,988 | $77,699,988 | $125,000,000 | 5 | May 7, 2018 | sec.gov |
| Sep 28, 2017 | New notice | $40,000,004 | $40,000,004 | $0 | 16 | Aug 15, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Joseph Kaminski | Executive Officer | |
| Carlos Ramirez | Executive Officer | |
| Gertjan Bartlema | Executive Officer | |
| John Sculley | Director | |
| Beth Steinbrenner | Executive Officer | |
| David Lemus | Director | |
| Henry Ji | Director | |
| Tim Smith | Executive Officer | |
| Andrew Pecora | Director | |
| Jaisim Shah | Director | |
| Xiaokui Zhang | Executive Officer | |
| Nassir Habboubi | Executive Officer | |
| Andrew von Eschenbach | Director | |
| Jodi Gurney | Executive Officer | |
| Curtis Quigley | Executive Officer | |
| Bill Waller | Executive Officer | |
| Peter Diamandis | Director | |
| Kok Thay Lim | Director | |
| John Haines | Executive Officer | |
| Robert Hariri | Executive Officer, Director | |
| Bill Maris | Director |
Other biotechnology companies in New Jersey that filed recently
- Ensho Therapeutics, Inc. $7.3 million · Oct 15, 2026
- Xenon Ophthalmics Inc $3.3 million · Oct 6, 2026
- LISATA THERAPEUTICS, INC. $351.9 million · Oct 2, 2026
Every Form D from the week of Nov 12, 2018 · All recent filings in New Jersey · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Celularity Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.